SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-19-010952
Filing Date
2019-11-13
Accepted
2019-11-13 17:11:27
Documents
55
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q cycc-20190930x10q.htm 10-Q 1517129
2 EX-31.1 cycc-20190930ex311796c41.htm EX-31.1 19339
3 EX-31.2 cycc-20190930ex3125aeaa2.htm EX-31.2 19929
4 EX-32.1 cycc-20190930ex321b489f8.htm EX-32.1 6783
5 EX-32.2 cycc-20190930ex3227f7c9e.htm EX-32.2 7373
  Complete submission text file 0001558370-19-010952.txt   4382087

Data Files

Seq Description Document Type Size
6 EX-101.INS cycc-20190930.xml EX-101.INS 687816
7 EX-101.SCH cycc-20190930.xsd EX-101.SCH 31436
8 EX-101.CAL cycc-20190930_cal.xml EX-101.CAL 40828
9 EX-101.DEF cycc-20190930_def.xml EX-101.DEF 123439
10 EX-101.LAB cycc-20190930_lab.xml EX-101.LAB 275101
11 EX-101.PRE cycc-20190930_pre.xml EX-101.PRE 235051
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Filer) CIK: 0001130166 (see all company filings)

IRS No.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-50626 | Film No.: 191215122
SIC: 2834 Pharmaceutical Preparations